Non-Alcoholic Steatohepatitis (NASH) Market Size, Share, Growth Trends By 2033 - PowerPoint PPT Presentation

About This Presentation
Title:

Non-Alcoholic Steatohepatitis (NASH) Market Size, Share, Growth Trends By 2033

Description:

Global non-alcoholic steatohepatitis (nash) market size is expected to reach $14.53 Bn by 2028 at a rate of 33.7%, segmented as by type, solid, liquid – PowerPoint PPT presentation

Number of Views:0
Date added: 14 March 2024
Slides: 9
Provided by: Bhuvantbrc7
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Non-Alcoholic Steatohepatitis (NASH) Market Size, Share, Growth Trends By 2033


1
Non-Alcoholic Steatohepatitis (NASH) Market
Report 2024
Market Size, Trends and Global Forecast 2024-2033
2
Non-Alcoholic Steatohepatitis (NASH) Market
Segments
The Business Research Company segments its
Non-Alcoholic Steatohepatitis (NASH) Market
report as
Solid, Liquid
By Type
Vitamin E and Pioglitazone, Ocaliva, Elafibranor,
Selonsertib and Cenicriviroc, Other Products
By Product
Hypertension, Heart Disease, High Blood Lipid,
Type 2 Diabetes, Obesity
By Disease Cause
By Sales Channel
Hospital Pharmacy, Retail Pharmacy, Online
Provider
By Application
Oral, Parenteral
3
Non-Alcoholic Steatohepatitis (NASH) Market
Statistics
It will grow from 3.33 billion in 2023 to 4.54
billion in 2024 at a compound annual growth rate
(CAGR) of 36.3. It will grow to 14.53 billion
in 2028 at a compound annual growth rate (CAGR)
of 33.7
Click Here To Get A Sample Report
4
Key Market Drivers And Trends
Drivers
The rising cases of obesity is driving the demand
for the non-alcoholic steatohepatitis (NASH)
market going forward.
Trends
Technological advancement is a key trend gaining
popularity in the non-alcoholic steatohepatitis
(NASH) market.
Region
North America was the largest region in the non
alcoholic steatohepatitis (NASH) market share in
2023. The regions covered in the non-alcoholic
steatohepatitis (nash) market report are
Asia-Pacific, Western Europe, Eastern Europe,
North America, South America, Middle East, Africa.
5
Key Market Players
  • Major players in the Non-Alcoholic
    Steatohepatitis (NASH) Market are
  • NGM Biopharmaceuticals Inc
  • Novartis AG
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche AG
  • And more.

6
5 Reasons Why TBRC Is The Solution You Need
  1. Measure the impact of high global inflation on
    market growth
  2. Outperform competitors using forecast data and
    the drivers and trends shaping the market
  3. Get a comprehensive market sizing report with a
    truly global perspective covering 60 geographies
    from The Business Research Company, with data
    from 2017 to 2024 and forecasts up to 2033.
  4. Assess the Russia-Ukraine wars impact on
    commodity supply and its direct and indirect
    impact on all the markets
  5. Benchmark performance against key competitors.

7
Americas The Business Research Company, 1295 N
Providence Rd, Media, PA 19063, USA ? 1
3156230293
Get In Touch
Europe The Business Research Company 47 Anchorage
Point, 42 Cuba Street, Canary Wharf, London,
England, E14 8NE ? 44 207 1930 708
How ever you want to grow and expand, The
Business Research Company can help as we provide
research consulting solutions for businesses,
government agencies consultancies, and market
research companies.
Asia The Business Research Company, 1st Floor,
Anshu Colors Building, Road Number 1, Park View
Enclave, Jubilee Hills, Hyderabad (India),
500033 ? 91 8897263534
info_at_tbrc.info
8
Your Growth Insights Partner
Write a Comment
User Comments (0)
About PowerShow.com